Your browser is no longer supported. Please, upgrade your browser.
Settings
OCGN [NASD]
Ocugen, Inc.
Index- P/E- EPS (ttm)-0.36 Insider Own0.50% Shs Outstand188.17M Perf Week-14.09%
Market Cap1.70B Forward P/E2.07 EPS next Y3.98 Insider Trans-42.68% Shs Float182.53M Perf Month19.28%
Income-34.40M PEG- EPS next Q0.38 Inst Own7.60% Short Float20.29% Perf Quarter-25.11%
Sales0.04M P/S39910.28 EPS this Y79.00% Inst Trans3.23% Short Ratio0.57 Perf Half Y2572.08%
Book/sh0.13 P/B63.31 EPS next Y81.09% ROA-86.70% Target Price9.00 Perf Year2531.07%
Cash/sh0.12 P/C70.87 EPS next 5Y- ROE-125.70% 52W Range0.17 - 18.77 Perf YTD349.73%
Dividend- P/FCF- EPS past 5Y70.80% ROI- 52W High-56.15% Beta4.51
Dividend %- Quick Ratio7.20 Sales past 5Y- Gross Margin- 52W Low4741.18% ATR1.80
Employees15 Current Ratio7.20 Sales Q/Q- Oper. Margin- RSI (14)44.98 Volatility21.32% 20.25%
OptionableYes Debt/Eq0.09 EPS Q/Q-106.80% Profit Margin- Rel Volume0.82 Prev Close8.61
ShortableYes LT Debt/Eq0.08 EarningsMay 07 BMO Payout- Avg Volume65.01M Price8.23
Recom2.20 SMA20-15.22% SMA50-5.05% SMA200131.50% Volume53,110,355 Change-4.41%
May-07-21Downgrade Cantor Fitzgerald Overweight → Neutral
Feb-09-21Downgrade Chardan Capital Markets Buy → Neutral $0.70 → $13
Feb-04-21Upgrade H.C. Wainwright Neutral → Buy $4.50
May-13-21 06:30AM  
May-12-21 08:38AM  
May-11-21 06:38AM  
May-10-21 03:42PM  
May-08-21 06:06AM  
May-07-21 10:01PM  
12:24PM  
11:40AM  
10:44AM  
10:37AM  
10:07AM  
07:30AM  
06:45AM  
06:15AM  
06:10AM  
May-06-21 12:32PM  
12:28PM  
09:05AM  
07:30AM  
May-05-21 06:30AM  
May-04-21 07:53PM  
06:03AM  
May-03-21 06:36PM  
04:35PM  
10:51AM  
10:48AM  
08:07AM  
07:30AM  
06:50AM  
Apr-30-21 06:04AM  
Apr-28-21 08:00AM  
06:01AM  
Apr-27-21 07:00AM  
04:33AM  
Apr-26-21 07:18PM  
11:55AM  
Apr-25-21 06:06AM  
Apr-23-21 09:06PM  
03:00PM  
02:45PM  
11:23AM  
06:15AM  
Apr-22-21 05:25PM  
01:35PM  
12:45PM  
10:37AM  
08:39AM  
06:54AM  
Apr-21-21 03:41PM  
08:19AM  
Apr-20-21 06:25AM  
Apr-16-21 01:52PM  
Apr-15-21 06:01AM  
Apr-14-21 08:00AM  
Apr-10-21 06:06AM  
Apr-07-21 05:58AM  
Apr-05-21 08:30AM  
Apr-04-21 07:23AM  
Apr-01-21 05:50PM  
Mar-29-21 08:54AM  
Mar-26-21 11:53AM  
Mar-25-21 10:00AM  
Mar-23-21 07:31AM  
Mar-22-21 01:15PM  
Mar-21-21 01:00PM  
Mar-18-21 09:30PM  
06:02PM  
01:00PM  
07:30AM  
06:30AM  
06:16AM  
Mar-16-21 07:48AM  
Mar-15-21 06:28PM  
05:45PM  
06:00AM  
Mar-13-21 06:00AM  
Mar-12-21 05:45PM  
12:32PM  
Mar-08-21 05:45PM  
02:50PM  
10:12AM  
Mar-07-21 08:00AM  
08:00AM  
Mar-06-21 06:04AM  
Mar-03-21 05:03PM  
12:33PM  
11:51AM  
08:20AM  
08:00AM  
07:20AM  
05:12AM  
Feb-26-21 06:57AM  
Feb-24-21 06:09AM  
Feb-23-21 07:30AM  
Feb-20-21 10:00AM  
Feb-19-21 06:01AM  
Feb-18-21 06:15AM  
06:04AM  
Feb-17-21 06:25AM  
Feb-16-21 12:38PM  
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tammara VijaySenior Vice PresidentMay 04Option Exercise0.8115,71112,7556,500May 05 08:15 PM
Tammara VijaySenior Vice PresidentMay 04Sale13.6815,711214,9540May 05 08:15 PM
Musunuri ShankarChief Executive OfficerMay 03Option Exercise0.51195,80999,863601,809May 03 09:00 PM
Tammara VijaySenior Vice PresidentMay 03Option Exercise0.464,3171,9864,317May 03 08:53 PM
Kompella UdayDirectorMay 03Sale15.0150,000750,500550,674May 03 09:05 PM
Musunuri ShankarChief Executive OfficerMay 03Sale14.24195,8092,788,320406,000May 03 09:00 PM
Potti ManishDirectorMay 03Sale15.0260,000901,20063,429May 05 08:13 PM
Potti ManishDirectorMay 03Sale15.0128,000420,2800May 05 08:13 PM
Tammara VijaySenior Vice PresidentMay 03Sale16.004,31769,0720May 03 08:53 PM
Kompella UdayDirectorApr 30Option Exercise0.5120,00010,200620,674May 03 09:05 PM
Kompella UdayDirectorApr 30Sale11.5620,000231,200600,674May 03 09:05 PM
Tammara VijaySenior Vice PresidentApr 29Option Exercise0.7529,99122,44212,880May 03 08:53 PM
Subramanian SanjayChief Financial OfficerApr 29Option Exercise2.197,99017,49853,581May 03 09:06 PM
Subramanian SanjayChief Financial OfficerApr 29Sale10.987,99087,73045,591May 03 09:06 PM
Tammara VijaySenior Vice PresidentApr 29Sale10.9729,991328,8810May 03 08:53 PM
Kompella UdayDirectorApr 26Sale11.70350,0004,095,000600,674Apr 28 06:52 PM
Kumar RameshDirectorApr 19Option Exercise0.517,5003,8257,500Apr 21 04:16 PM
Kumar RameshDirectorApr 19Sale5.337,50039,9750Apr 21 04:16 PM
Potti ManishDirectorMar 05Option Exercise0.8428,00023,52028,000Mar 08 08:38 PM
Subramanian SanjayChief Financial OfficerJan 29Option Exercise0.5135,59118,15145,591Feb 01 05:31 PM
Castillo KirstenDirectorMay 28Buy0.3175,00023,49875,000May 29 06:48 PM